Andre W. Bourgoyne: Anemia Management as a Comprehensive Hospital Performance Strategy
Andre W. Bourgoyne, Bloodless Program Consultant at UChicago Medicine shared a post on LinkedIn:
“Anemia Management Is a Hospital Performance Strategy – Not Just a Lab Value
Preoperative anemia is one of the strongest predictors of surgical complications, longer hospital stays, and increased mortality.
Yet many hospitals still treat anemia reactively.
Forward-thinking institutions are shifting to Preoperative anemia management initiatives.
Why it matters:
- Fewer transfusions
- Lower complication rates
- Reduced ICU utilization
- Shorter length of stay
- Improved quality metrics
- Stronger financial performance
Optimizing hemoglobin before surgery with IV iron, B12, folate, nutrition, and appropriate EPO support doesn’t just protect patients – it protects institutional outcomes.
Anemia management is:
- Risk reduction
- Cost containment
- Outcome optimization
- Strategic differentiation
Hospitals that strengthen the blood before surgery strengthen their brand, their margins, and their mission.
Stay updated with Hemostasis Today.
-
Jun 23, 2026, 23:05Rounak Dubey: ISBT Academy Session on Agentic AI
-
Jun 23, 2026, 22:59Mohammed Maher Babiker: Don’t Let EDTA Fool You – When ‘Low Platelets’ aren’t Really Low
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 22:03Erin VanDyke: A Journey Through VTE Leadership and Healthcare Transformation
-
Jun 23, 2026, 20:30Aladdin Mohammad: Baseline IgG as a Key Predictor of Hypogammaglobulinaemia in AAV
-
Jun 23, 2026, 19:20Simos Kokkovos: 1st Ever Mobile Stroke Unit in Greece is on its way to Metropolitan Hospital
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation